Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
78 hedge funds and large institutions have $56.5M invested in Spectrum Pharmaceuticals Inc in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 11 closing their positions.
299% more call options, than puts
Call options by funds: $611K | Put options by funds: $153K
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
69% more capital invested
Capital invested by funds: $33.4M → $56.5M (+$23M)
13% more funds holding
Funds holding: 69 → 78 (+9)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.82M |
| 2 |
AC
Armistice Capital
New York
|
+$3.26M |
| 3 |
E
Ergoteles
New York
|
+$2.3M |
| 4 |
NYLIM
New York Life Investment Management
New York
|
+$1.36M |
| 5 |
CM
Crystalline Management
Montreal, Quebec,
Canada
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$797K |
| 2 |
Millennium Management
New York
|
-$333K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$195K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$194K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$162K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LC
76
Lindbrook Capital
Calabasas,
California
| $1 | – | – | – |
|
|
IC
77
Ikarian Capital
Dallas,
Texas
| – | -$133K | -176,980 | Closed |
|
|
BCM
78
Bridgeway Capital Management
Houston,
Texas
| – | -$113K | -150,000 | Closed |
|
|
WG
79
Winton Group
London,
United Kingdom
| – | -$81.9K | -109,140 | Closed |
|
|
BFM
80
Boothbay Fund Management
New York
| – | -$22.8K | -30,401 | Closed |
|
|
TSS
81
Two Sigma Securities
New York
| – | -$18.4K | -24,553 | Closed |
|
|
ECM
82
ExodusPoint Capital Management
New York
| – | -$18K | -24,300 | Closed |
|
|
WMA
83
West Michigan Advisors
Holland,
Michigan
| – | -$12.8K | -17,000 | Closed |
|
|
MC
84
Moors & Cabot
Boston,
Massachusetts
| – | -$9.3K | -12,400 | Closed |
|
|
IAA
85
Independent Advisor Alliance
Charlotte,
North Carolina
| – | -$8.1K | -10,800 | Closed |
|
86
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7.23K | -7,314 | -100% |
|
|
KM
87
Kalos Management
Alpharetta,
Georgia
| – | -$150 | -200 | Closed |
|
|
TWA
88
TCI Wealth Advisors
Tucson,
Arizona
| – | -$75 | -100 | Closed |
|
SPPI Hedge Fund Activity: Q2 2023 in Review
78 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2023, worth a combined $56.5M — up 69% from $33.4M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new SPPI positions and 11 closed out — a net gain of 9 holders — while 13 added to existing stakes and 21 trimmed.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $4.82M. The largest seller was Acadian Asset Management, cutting an estimated $797K.
- 78 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2023, up from 69 in Q1 2023.
- Funds reported $56.5M of Spectrum Pharmaceuticals Inc stock for Q2 2023, up 69% quarter-over-quarter.
- 20 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2023 and 11 closed out, a net change of +9 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q2 2023 was Kennedy Capital Management, an estimated $4.82M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q2 2023 was Acadian Asset Management, an estimated $797K sold.
Based on aggregated 13F filings for Q2 2023.